These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 841106)

  • 21. Prostaglandin X, the vascular metabolite of arachidonic acid responsible for relaxation of bovine coronary artery strips [proceedings].
    Dusting GJ; Lattimer N; Moncada S; Vane JR
    Br J Pharmacol; 1977 Mar; 59(3):443P. PubMed ID: 843691
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostacyclin, its fatty acid precursor and its metabolites on the inotropic function of and on the prostanoid generation by diabetic arteries.
    Sterin-Borda LJ; Franchi AM; Borda ES; del Castillo E; Gimeno MF; Gimeno AL
    Biomed Biochim Acta; 1984; 43(8-9):S257-64. PubMed ID: 6440539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ouabain inhibits endothelium-dependent relaxations to arachidonic acid in canine coronary arteries.
    Rubanyi GM; Vanhoutte PM
    J Pharmacol Exp Ther; 1985 Oct; 235(1):81-6. PubMed ID: 3930700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotransformation and cardiovascular effects of arachidonic acid in the dog.
    Mullane KM; Dusting GJ; Salmon JA; Moncada S; Vane JR
    Eur J Pharmacol; 1979 Mar; 54(3):217-28. PubMed ID: 428423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Responses to prostaglandins H2 and I2 of isolated dog cerebral and peripheral arteries.
    Toda N
    Am J Physiol; 1980 Feb; 238(2):H111-7. PubMed ID: 6987901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a novel metabolic pathway of arachidonate in coronary arteries which generates a potent endogenous coronary vasodilator.
    Raz A; Isakson PC; Minkes MS; Needleman P
    J Biol Chem; 1977 Feb; 252(3):1123-6. PubMed ID: 838699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the rabbit transverse stomach-strip to identify and assay prostacyclin, PGA2, PGD2 and other prostaglandins.
    Whittle BJ; Mugridge KG; Moncada S
    Eur J Pharmacol; 1979 Jan; 53(2):167-72. PubMed ID: 759196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelium-dependent and independent responses to prostaglandin H2 and arachidonic acid in isolated dog cerebral arteries.
    Toda N; Inoue S; Bian K; Okamura T
    J Pharmacol Exp Ther; 1988 Jan; 244(1):297-302. PubMed ID: 3121847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane a2.
    Miller OV; Johnson RA; Gorman RR
    Prostaglandins; 1977 Apr; 13(4):599-609. PubMed ID: 193153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the formation and effects of thromboxane A2 in human platelets.
    Svensson J; Hamberg M; Samuelsson B
    Acta Physiol Scand; 1976 Nov; 98(3):285-94. PubMed ID: 998278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of prostagladin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and certain other smooth muscle preparations [proceedings].
    Bunting S; Moncada S; Vane JR
    Br J Pharmacol; 1976 Jul; 57(3):462P-463P. PubMed ID: 974353
    [No Abstract]   [Full Text] [Related]  

  • 32. Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin.
    Aiken JW; Shebuski RJ; Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 7():635-9. PubMed ID: 6245568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion.
    Charo IF; Feinman RD; Detwiler TC; Smith JB; Ingerman CM; Silver MJ
    Nature; 1977 Sep; 269(5623):66-9. PubMed ID: 895887
    [No Abstract]   [Full Text] [Related]  

  • 34. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
    Pratt PF; Hillard CJ; Edgemond WS; Campbell WB
    Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsomal preparations of normal bovine iris-ciliary body generate prostacyclin-like but not thromboxane-A2-activity.
    Kulkarni FS; Eakins HM; Saber WL; Eakins KE
    Prostaglandins; 1977 Oct; 14(4):689-700. PubMed ID: 339281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostacyclin stimulation of dog arterial cyclic AMP levels.
    Miller OV; Aiken JW; Hemker DP; Shebuski RJ; Gorman RR
    Prostaglandins; 1979 Dec; 18(6):915-25. PubMed ID: 232764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of arachidonic acid metabolism modulate adenosine relaxation in isolated coronary arteries.
    Rubanyi GM; Paul RJ
    Blood Vessels; 1985; 22(5):209-16. PubMed ID: 3933595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modifications of canine vascular smooth muscle responses to dihydroergotamine by endogenous prostaglandin synthesis.
    MULLER-Schweinitzer E; Brundell J
    Eur J Pharmacol; 1975 Nov; 34(1):197-206. PubMed ID: 1234762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.